MedPath

Effect Of Pratimarsha Nasya With Shatapushpa Taila And Tila Taila In Oligomenorrhea.

Phase 2
Not yet recruiting
Conditions
Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,
Registration Number
CTRI/2023/08/056441
Lead Sponsor
Dr Netra Karjagi
Brief Summary

- *Streeroga* includes an array of diseases, among which *Artava Dushti* indicates menstrual disorders. The ultimate effect of *Artava Vyapath* is *Abeejatva*, diagnosis and treatment of *Artava Vyapath* is essential

- *Artava Kshaya* is a condition in which menstruation fails to occur at appropriate time (delayed) with scanty flow and does not last for 3 days.3

- A similar entity in contemporary science, where menstrual bleeding occurring more than 35 days apart and which remains constant at the frequency is called oligomenorrhea.

- The treatment opted in modern system of medicine is hormonal therapy, which may have adverse effect on body like obesity, nausea, vomiting, endometrial cancer and breast cancer.

- Acharya says “*Nasa Hi Shiraso Dwaram*†i.e. *Nasa* is said to be the door of *Shiras* because *Nasa* is indirectly connected with the brain centers in the head.

- As *Nasya* helps in regulating hypothalamus where GnRH is produced and is also connected with pituitary gland which produces hormones like FSH, LH, estrogen, progesterone and prolactin thus resulting in regulation of HPO axis.

- *Nasya* is very convenient to the patients due to its easy procedure and less requirement of time. Hence *Shatapushpa Taila* and *Tila Taila Nasya* is expecting to benificial results in *Artavakshaya* and hence taken for the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • 1.Subjects of age group between 18 years to 40 years.
  • 2.Both married and unmarried women.
  • 3.Subjects presenting with classical symptoms of Artava Kshaya.
  • 4.Subjects presenting with symptoms of Oligomenorrhea.
  • 5.Subjects with Poly Cystic Ovaries.
Exclusion Criteria
  • 1.Subjects with history of PID, Tuberculosis, Pelvic Endometriosis, Adenomyosis.
  • 2.Subjects with known cases of Hypertension, Thyroid disorders, Anemia.
  • 3.Subjects with any known case of Benign and Malignant tumors.
  • 4.Subjects with Congenital Anomalies.
  • 5.Nasya Ayogya.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in flow of menstrual bleeding, Interval between 2 cyclesBefore treatment 0th day | after treatment - after subjects gets her cycle
Secondary Outcome Measures
NameTimeMethod
Reduction of pain during menstruation, number of pads.0th Day ,After subject gets her cycle (Maximum study duration 42 days)

Trial Locations

Locations (1)

Sri Sri College of Ayurvedic Science and Research

🇮🇳

Bangalore, KARNATAKA, India

Sri Sri College of Ayurvedic Science and Research
🇮🇳Bangalore, KARNATAKA, India
Dr Netra Karjagi
Principal investigator
07204978431
netratkarjagi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.